| Title |
|
|
|
Development of (6R)-2-Nitro-644-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b ][1,3]oxazine (DNDI-8219) : a new lead for visceral Leishmaniasis
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Journal of medicinal chemistry. - Washington, D.C., 1963, currens | |
| Publication |
|
|
|
Washington, D.C. : 2018
| |
| ISSN |
|
|
|
0022-2623
| |
| Volume/pages |
|
|
|
61:6(2018), p. 2329-2352
| |
| ISI |
|
|
|
000428356600010
| |
| Full text (Publisher's DOI) |
|
|
| | |
|